As conversations around cannabis policy reform gain momentum, a crucial aspect often gets overshadowed – medical marijuana. While the push for adult-use legalization grabs headlines, the role of medical cannabis in policy debates has become less prominent, despite its foundational importance.
Luna Stower, Chief Impact Officer at Ispire and upcoming speaker at the Benzinga Cannabis Capital Conference, is urging a renewed focus on medical marijuana in policy discussions. Stower points out that while recreational cannabis markets might generate significant revenue, medical marijuana continues to play a vital role for countless patients. “Medical cannabis remains the foundation of the movement, providing critical relief to patients who rely on it for conditions like chronic pain, epilepsy, and PTSD,” she explains. The therapeutic benefits of medical marijuana, she argues, should not be overlooked in policy debates, especially considering the positive impact it has on public health.
Despite its crucial role, medical cannabis has not been a priority in recent legislative efforts compared to adult-use markets. Stower also highlights the role of medical marijuana in shaping global cannabis regulations. “Its therapeutic potential still plays a crucial role in shaping global regulations, particularly in countries that are more hesitant about full legalization,” she states. While many countries remain cautious about adopting adult-use cannabis laws, medical marijuana has paved the way for reform in more conservative markets.
Stower believes it’s crucial to continue advocating for medical cannabis as a distinct issue in policy-making. As the industry continues to evolve, Stower emphasizes the importance of keeping medical marijuana at the forefront of policy discussions. “We need to continue advocating for medical cannabis as a separate and necessary discussion in policy, as it addresses public health in ways that go far beyond recreational use,” she states. Stower’s perspectives underscore the need to not only focus on the commercial potential of cannabis but also to ensure that medical marijuana remains a core part of the conversation. These insights will be part of a broader discussion at the Benzinga Cannabis Capital Conference, where industry leaders will explore the future of cannabis policy, investment, and market trends.
